SOLUtion Medical

Simplifying Adrenal Crisis Health Management

We are passionate about what we do

SOLUtion is an early-stage life science company based in Philadelphia, PA  developing more patient friendly drug delivery systems for reconstitutable drugs. We specifically aim to improve the administration efficacy of life-saving injectable medication with our TwistJect™ auto-injector for people living with adrenal insufficiency including Addison’s Disease and Congenital Adrenal Hyperplasia.


Join us in making history

Adrenal crisis: Still a deadly event in the twenty first century

Adrenal crisis is a life-threatening medical emergency, associated with a high mortality unless it is appropriately recognized and early treatment is rendered. Nearly 144 million people worldwide are adrenal insufficient (AI). Despite it being a treatable condition for almost 70 years, failure of adequate preventive measures or delayed treatment has often led to unnecessary deaths. 1,2


Current standard of care

The current standard of care in times of adrenal crisis includes the Act-o-vial®. This medical packaging requires an average of twelve user steps for injection, and was designed to be utilized by trained medical personnel, not a layperson or an individual living with adrenal insufficiency. 

1 %
adherence rate using current standard of care
1 X
more likely to be hospitalized
$ 1 K
per hospitalization event

Patient Voices

TwistJect ™ provides people reliable, accurate, and intuitive life-saving care.​​




Accelerators and collaborators

SOLUtion Medical has been recognized for its innovative approach to adrenal crisis health management with its patent-pending TwistJect™  device. Since inception in 2019, SOLUtion Medical has gained recognition throughout Philadelphia and within the adrenal insufficient community.


Philadelphia, PA
(484) 416 -1261

1) Huecker MR, Dominique E. Adrenal Insufficiency. [Updated 2019 May 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan.

2) Am J Med. 2016 Mar;129(3):339.e1-9. doi: 10.1016/j.amjmed.2015.08.021. Epub 2015 Sep 9.



© 2020 All rights reserved